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Abstract
Background. Whether written feedback on drug prescribing in general practice affects prescribing habits is controversial. Most
short-term studies showed no effect. However, the issue has not been tested in long-term studies involving the local general
practitioner community.
Aims of the study. To assess whether prescribing levels in general practice are affected by long-term, unsolicited, systematically
repeated, mailed feedback.
Methods. Each of the 94 general practices in Storstrøm County, Denmark, received semi-annual, mailed feedback about their
prescribing volumes and costs within 13 major drug groups, in relation to the levels for all the other 93 practices over a 7-year
period in a project initiated by the local general practitioner association. Data on the number of deﬁned daily doses (DDDs)
prescribed per 1000 listed patients in each practice per 6-months, and practice characteristics, were obtained from the
Pharmaceutical Database at the County Health Department.
Results. There was a large variation in drug prescribing volume between practices, but little within-practice variation over time.
After adjustments for the inﬂuence of practice size and other potential outcome-affecting variables, there was no evidence of a
general change of prescribing volume over time, no change among practices with a high or a low prescribing level, and no
signiﬁcant change within the various drug groups.
Conclusions. We found no signiﬁcant effects on prescribing levels of mailed feedback, even when repeated semi-annually during
7 years and initiated by the local general practitioner community.
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Introduction
Drug prescribing in general practice is subject to
attention from all interested parties. In Scandinavia,
the majority of prescriptions, regardless of medical
specialty, are issued by general practitioners (GPs)
(1,2). Signiﬁcant variations in prescribing habits
among GPs have been shown (3,4), which to a certain
extent may be explained by variations in demographic
factors, including patient age, sex, and diagnostic
panorama (‘case mix’). There may, however, be as
yet unidentiﬁed additional reasons for these varia-
tions, such as the prescribing habits of individual GPs.
The ‘optimum’ prescribing proﬁle for a practice
is difﬁcult to deﬁne. A basic step in the drug pre-
scribing quality assessment process is to become
aware of one’s own prescribing proﬁle. This may be
accomplished by displaying the prescribing proﬁle of a
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practices in the area, for instance by mailed feedback.
Whether this undertaking is enough to start a perpet-
ual rational drug therapy review on the practice level
has been debated (4,5). The effect of mailed feedback
is controversial. In a number of studies no effect was
found (6–9), whereas others have reported limited
positive effects in general practice of postal feedback
of prescribing proﬁles for selected drug groups
combined with treatment recommendations (10,11).
In 1991 an initiative was launched to improve drug
prescribing among GPs in the former Storstrøm
County, Denmark. During fourteen 6-month periods,
mailed feedback to the individual practices was used
to encourage GPs to review their drug therapy proﬁle
and, if needed, reconsider their prescribing practices.
In this report the effect of this unsolicited, semi-
annually mailed feedback on intra- and inter-practice
variations in drug prescribing was assessed.
Material and methods
Setting
The former Storstrøm County is today part of the
larger administrative unit Region Sjælland. At the
time of the study it included the southern part of
Sjælland, the islands of Falster and Lolland, and a
few other minor islands, and had 257,000 residents.
The area ismainlyrural witha few small towns and was
served by 166 general practitioners distributed across
94 practices.
In Denmark the general practitioners are private
contractors to the County Health Authority, each
taking care of approximately 1500 listed patients.
Each practice has a speciﬁc identiﬁcation number
(PIN) within the National Health Insurance system.
All relevant information related to administration and
fees in the practices, such as patient demographics,
prescriptions (obtained from the Danish Medicines
Agency), referrals, and speciﬁc services and treat-
ments performed in the practice, is registered in the
local County Health Insurance database.
Traditionally, most practices in primary health
care in Denmark have been ‘solo’ practices (run by
one GP), but in recent decades the formation of
group practices has become increasingly common.
In group practices it is not possible to identify the
individual GP’s contribution to the common prescrib-
ing proﬁle, since the PIN refers to the practice as a
whole. The population of listed patients in the
practice system is stable, with an average annual
change between practices of less than 10%. The
differences between practice patient populations in
terms of age and gender are small (personal commu-
nication from the Pharmacoeconomic Division, Dan-
ish Medicines Agency).
Data collection
All prescriptions ﬁlled at Danish pharmacies, reim-
bursed as well as non-reimbursed, are registered in a
database at the Danish Medicines Agency by practice
PIN code and anatomical therapeutic chemical
(ATC) code (12). The registration is almost 100%
complete. All prescriptions analysed in this report
were fully reimbursed.
In 1991 the ﬁrst steps were taken to establish a ‘GP
Quality Unit’ by collaboration between representa-
tives from general practice and ofﬁcials from the
health administration within the Health Department
of Storstrøm County. The aim was to encourage a
review among GPs of their prescribing habits in order
to improve and enhance rational drug therapy. To
visualize differences in prescribing habits and to trig-
ger the awareness of the GPs, prescribing data on
reimbursed pharmaceuticals with the ATC codes A02
(antacids), A10 (anti-diabetes drugs), C01 (cardiac
drugs), C03 (diuretics), C07 (beta-blockers), C08
(calcium channel-blockers), G03 (reproduction hor-
mones), J01 (anti-bacterial drugs for systemic use),
M01 (non-steroid anti-inﬂammatory drugs), N02
(analgesics), N05 (neuroleptic drugs), N06 (psy-
cho-analeptic drugs), and R03 (anti-asthma drugs)
were extracted from the County Health Insurance
database, presented in charts, and mailed to each
practice every 6 months. No intervention other
than the mailed feedback was made.
The feedback diagrams illustrated the prescribing
levels of each of the 13 drug groups as number of
deﬁned daily doses (DDD) per 1000 listed patients
and the practice’s percentile position within the dis-
tribution across all practices in the county. The cor-
responding information on costs per DDD prescribed
by the practice was presented in a similar way.
An example of the feedback diagrams is shown in
Figure 1. Every 6 months new data were added to the
charts and mailed to the practices.
If this type of feedback works, the anticipated effect
would be a clustering of prescribed DDDs towards
the mean, i.e. a smaller dispersion between practices
and a tendency towards instability of individual prac-
tice prescribing patterns over time owing to changing
habits. Since the initiative for political reasons was
launched full scale simultaneously in all practices
throughout the county, no control group was avail-
able. Therefore, the prescribing habits of all practices
were followed through the study period.
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Statistical considerations
Statistical analyses were performed using the SAS
software, version 9.1 (13). Data were complete. Sim-
ple (crude) differences between groups regarding
continuous variables were tested with Student’s
t test and differences in proportions with the chi-
square test.
During the observation period 1992–1998 a few
new practices were established. This might have given
rise to false low values regarding the numbers of
prescribed DDD/1000 patients in the opening period.
To avoid this problem, data from the ﬁrst 6-month
period of new practices were excluded.
In order to discover and test changing habits four
methods were employed. The ﬁrst focused on intra-
practice variation of prescribing habits, where varia-
tion would increase in case of changing habits. The
prescribing data constitute a time-series of prescrip-
tions issued by the same GP population. The resulting
DDDs may therefore be auto-correlated, i.e. the value
for a speciﬁc 6-month period predicts, to a certain
extent, the value of the next period. To overcome this
problem the SAS procedure ‘autoreg’ was used to
diagnose and to adjust for auto-correlation. The
adjustment included the nearest three 6-month per-
iods, as these were signiﬁcantly auto-correlated. The
resulting adjusted measure of variability, mean square
error (MSE), may be regarded as a variance adjusted
for prescribing trend across time. We used the square
root of this measure, which is equivalent to a standard
deviation unit, as a measure of prescribing variability
within practices over time.
The second method was based on the so-called
‘folding rule’ regression analysis. The study period
was divided in two sub-periods, and a regression line
of prescribed DDDs per 1000 listed patients over time
was calculated for each practice and for each sub-
period, much like a folding rule. The meeting-point,
or intersection, between the lines was successively
moved across the study period. A signiﬁcant differ-
ence in regression coefﬁcient (‘leaning’) between the
two lines would then indicate a change of subscribing
habit. In this way the existence of a systematic devi-
ation towards the central part of the prescribing
distribution might be detected.
Thirdly, the change in the distribution of DDD per
1000 listed patients across the fourteen 6-month
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Figure 1. Example of feedback information sheet. The left-hand panel presents data regarding the amount of drugs, in this case antibiotics,
prescribed. The right-hand panel presents cost data. The dotted line represents the prescribing level of a speciﬁc practice relative to all practices
in the county. The vertical scale corresponds to the 5th, 25th, 75th, and 95th percentiles of the distribution across all practices. DDD = deﬁned
daily doses; AUP = costs in Danish kroner per DDD.
240 K. Vægter et al.periods was tested. If a change of habit had occurred,
the distribution would be narrower towards the end of
the study period than in the beginning.
Fourthly, scatter plots of the prescription volumes
for each practice over time were produced and scru-
tinized for change of trend.
Univariate and multivariate linear regression anal-
yses were used to analyse the inﬂuence of various
potential determinants, such as age and sex of the
listed patients (‘case mix’), age and sex of the GPs,
practice type, and number of years of experience as a
GP, on prescribing variation, measured as mean
error, or on practice regression coefﬁcients. All tests
were two-tailed. The level of signiﬁcance was set at
P < 0.05.
Results
Characteristics of the study population
Study population characteristics are shown in Table I.
Fifty-four practices were solo practices, and 50 were
group practices with an average of 3.2 GPs per prac-
tice. The 166 GPs were on average 50 years old
(interquartile range 46–54 years), 81% were men,
mean number of years as a GP was 14.5 (interquartile
range 8–20 years). There were no signiﬁcant differ-
ences in the distribution of age, sex, and GP
experience between GPs in solo versus group
practices.
Prescribing habits over time
The overall prescribing rate of the 13 drug groups
studied increased from 64,870 DDDs/1000 patients
in the ﬁrst 6 months of 1992 to 70,360 DDD/
1000 listed subjects in the last 6 months of 1998, an
annual increase rate of 915 DDD/1000 listed subjects.
The trends in prescribing rate for the various
drug groups are shown in Figure 2. The number of
DDDs per 1000 listed subjects prescribed during the
study period increased signiﬁcantly for antacids (A02),
anti-diabetes drugs (A10), beta-blockers (C07), cal-
cium channel-blockers (C08), reproduction hormones
(G03), analgesics (N02), psycho-analeptic drugs
(N06), and anti-asthma drugs (R03), while it
decreased for cardiac drugs (C01) and diuretics
(C03), and remained unchanged for antibiotics
(J01), non-steroid anti-inﬂammatory drugs (M01),
and neuroleptic drugs (N05).
Prescribing variation among practices
The variations between practices in amount of pre-
scribed drugs within the various ATC groups are
presented in Table II as semi-annual mean DDD/
1000 listed patients, the 95th and the 5th percentile of
the DDD distribution across practices, and the ratio
of these two. There were fairly large variations in
prescribing level between the practices, as reﬂected
by the 95th to 5th percentile ratios. The largest
differences were seen for neuroleptic drugs (ratio
6.0) and the smallest for anti-asthma drugs (ratio 2.5).
There was little variation over time within prescrib-
ing practices, as reﬂected by the root of the MSE, a
measure of the mean prescribing standard deviation
adjustedfortheincreasingordecreasingtrendlineover
the fourteen 6-month periods (Table II). The root
MSE was 0.20 units, one-ﬁfth of a standard deviation,
witha95%conﬁdenceinterval(CI)of0.18–0.23forall
drug groups combined after adjustment for auto-cor-
relation, indicating only minute deviations from the
trend line. Among the individual drug groups, analge-
sics (N02) and calcium channel-blockers (C08) had
the lowest variability and anti-diabetes drugs (A10) the
highest. The within-practice deviation range was 0.01–
1.08 for individual ATC groups.
In the folding rule regression analysis across all
practices there was no evidence of a deviation of
high or low prescribers towards the mean for all
GP practices, nor was there any signiﬁcant change
in the DDD per 1000 listed subjects distribution
Table I. Characteristics of the study population.
Solo practices Group practices Total
n Mean or % 95% CI n Mean or % 95% CI n Mean or % 95% CI
n 54 57.4 40 42.6 94 100.0
Age, years 54 50.3 48.7–51.9 112 49.9 48.7–51.1 166 50.0 49.1–51.0
Male physicians, % 46 85.2 75.4–95.0 88 78.6 70.9–86.3 134 80.7 74.7–86.8
No. of GPs in practice 54 1.0 – 112 3.2 2.9–3.4 166 1.77 1.54–1.99
No. of years as a GP 54 15.1 13.0–17.1 112 14.3 12.8–15.7 166 14.5 13.4–15.7
CI = conﬁdence interval; GP = general practitioner.
Mailed feedback on drug prescribing 241across time when adjusting for the increasing mean.
Scrutiny of practice-speciﬁc trend lines for the pre-
scribing levels of the various ATC groups gave no
evidence that high or low prescribing practices tended
to change their course (data not shown).
The solo practices had larger prescribing varia-
tions than group practices (0.30 SD units, 95%
CI 0.24–0.35, versus 0.19, 95% CI 0.15–0.23;
P < 0.005). Among the solo practices there was no
difference in prescribing variation between male and
Table II. Variation of drug prescribing habits, measured as mean standard deviation of prescribed DDD/1000 patients across the follow-
up period.
Drug group ATC code Semi-annual mean
a
Percentiles
Ratio
95th/5th
Root MSE
95th 5th Mean 95% CI Range
Antacids A02 2475.59 4377.0 1137.4 3.8 0.24 0.21–0.26 0.03–0.66
Anti-diabetes drugs A10 2460.11 3889.0 1304.4 3.0 0.30 0.27–0.33 0.03–0.73
Cardiac disease drugs C01 4689.73 8289.7 1981.4 4.2 0.30 0.26–0.34 0.03–1.08
Diuretics C03 19315.90 31723.8 10143.7 3.1 0.23 0.20–0.25 0.01–0.77
Beta-blockers C07 2845.88 4695.4 1366.0 3.4 0.25 0.22–0.28 0.02–0.81
Calcium channel-blockers C08 6123.94 10276.1 2747.2 3.7 0.20 0.18–0.22 0.01–0.61
Sex hormones G03 4642.50 7545.8 2089.0 3.6 0.22 0.20–0.24 0.03–0.65
Antibiotics J01 1433.18 2481.2 645.8 3.8 0.25 0.23–0.28 0.01–0.60
NSAIDs M01 5107.58 8171.3 2854.1 2.9 0.25 0.22–0.27 0.01–0.63
Analgesics N02 5374.84 9979.6 2416.6 4.1 0.20 0.17–0.22 0–0.55
Neuroleptics N05 1321.11 2852.4 474.5 6.0 0.23 0.20–0.26 0.01–0.90
Anti-depressants N06 3139.88 4501.1 1494.0 3.6 0.21 0.19–0.23 0.02–0.51
Anti-asthma drugs R03 9851.54 14575.7 5900.0 2.5 0.28 0.25–0.31 0–0.76
aDDD/1000 patients.
ATC = anatomical therapeutic chemical; CI = conﬁdence interval; DDD = deﬁned daily doses; NSAIDs = non-steroid anti-inﬂammatory
drugs; MSE = mean square error.
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242 K. Vægter et al.female GPs, but the variation decreased with
0.02 SD units by year of GP age. There were no
signiﬁcant relationships between age, sex, and num-
ber of years as GP on the one hand and prescribing
volume over time on the other (data not shown).
Discussion
There was a considerable variation in prescribing
levels between practices but a considerable stability
in the variation of prescribing behaviour over the
study period for individual practices, irrespective of
analysis method. The mailed feedback had no detect-
able effect on prescribing behaviour. As expected,
there was slightly more variation within solo practices
than within group practices because of the counter-
balancing effect of accumulated prescribing by of two
or more GPs in the group practices. The variation
decreased somewhat with GP age, and there were no
statistically signiﬁcant gender effects.
The analyses were performed on ofﬁcial data, based
on ﬁlled prescriptions, with little or no data loss. The
same authority registered all ﬁlled prescriptions, min-
imizing handling variation. Potential disturbing fac-
tors, such as auto-correlation, were eliminated during
data processing. It was not possible to establish a
control group within the county, as the quality
improvement initiative (‘GP Quality Unit’) aimed
at covering all practices. Comparison with other
counties was not possible, since data were not avail-
able for areas other than Storstrøm County. There-
fore, the practices served as their own controls over
time. Data refer to prescribing habits during the
1990s. However, the problem of rational prescribing
habits is still prevalent (11).
Few authors have addressed the issue of stability of
prescribing habits in general practice. One of the main
reasons may be the lack of comprehensive long-
term prescription data registers at prescribing physi-
cian level. In a New Zealand study from 1992–94 (5),
based on reimbursement data, a 9% median intra-
GP variability was found in both volume and total
costs from year to year in a regional GP sample
(305 GPs), and a 16% variation in total costs and
17% in total volume in a national GP sample
(74 GPs).
Our ﬁnding of no effects of mailed feedback on GPs’
prescribing behaviour conforms to what has been
shown in a comprehensive 2000 Cochrane review
(6). Similar results have also been shown in the few
studies where large data registers were used to collect
outcome measures. In a randomized controlled trial in
Australia (7), no effects were found of unsolicited,
posted government-sponsored feedback based on
centralized aggregated data on prescribing levels of
general practitioners. In a Danish randomized, con-
trolled trial it was concluded that postal prescribing
feedback in addition to clinical guidelines on the diag-
nosis and treatment of respiratory tract infections did
not inﬂuence GPs’ prescribing patterns (8,9).
However, there are studies that demonstrate some
effects. In a Canadian trial 54 GPs whose prescribing
of analgesics was more than two standard deviations
above average were randomly allocated to receiving a
note on their prescribing volume and a 1-day group
education activity, or to receiving a written notiﬁca-
tion only, or to no intervention (14). Those in the ﬁrst
group decreased their prescribing volume by 33%,
and those in the second group by 25%, while there
was no change in the third group. Similar but smaller
effects were found in a Norwegian study (10) and in a
Canadian study (11) when written feedback of
prescribing proﬁles was combined with treatment
recommendations. In a 2006 Cochrane review it
vwas found that the combination of audit and feed-
back had a small to moderate effect on professional
practice (15).
Although mailed feedback only has shown a modest
or no effect on doctors’ drug prescribing, it is still
widely used in continuing medical education (CME)
and in quality assurance and improvement. The
method is easy to apply on a large scale and relatively
cheap. However, the approach appears to be more
effective if combined with other strategies (16), such
as audit feedback with peer discussions (17,18).
Some possible explanations for the lack of success
with mailed feedback only in this study might be that
the GPs may not have paid attention to the diagrams,
or they may not have understood the diagrams, or
they may have taken the diagrams into consideration
but found no reason to chance their prescribing
habits. Moreover, too much information with poor
explanation may have been provided.
It is important to note that the establishing of the
‘GP Quality Unit’, the development of the feedback
charts, and the semi-annual mailed prescribing
feedback were some of the ﬁrst, but important, steps
in the process of establishing a formal local quality
improvement culture within the general practice com-
munity of Storstrøm County in the early 1990s. The
main purpose of the initiative was to initiate reﬂec-
tions on variations in prescribing behaviour and raise
awareness about prescribing patterns. The feedback
diagrams were not accompanied by any clinically
relevant information, and they were based on
aggregated prescribing data at the second ATC level
with no chance of identifying speciﬁc substances at
the ﬁfth ATC level. On the other hand, too detailed
prescribing information at this early stage in the
Mailed feedback on drug prescribing 243quality assurance process might possibly impede the
overall ambition of starting a debate about rational
drug prescribing in a broader sense.
Conclusions
No apparent effect of mailed feedback on prescribing
habits in general practice was found. Other, more
activating approaches than postal feedback may be
necessary to affect GPs’ prescribing behaviour.
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